Furthermore, CD44V3 knockdown significantly suppressed the expression of multiple stemness markers, including BMI1, KLF4, SOX2, and NANOG [41], indicating that, in accordance with CD44V, CD44V3 possesses stemness-maintaining ability and then promotes pancreatic cancer migration and invasion. This evidence concerns the gene SOX2 and pancreatic neoplasm.